This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kemmeren, J. M. Articles by Algra, A. Search for Related Content PubMed PubMed Citation Articles by Kemmeren, J. M. Articles by Algra, A. Related Collections Primary and Secondary Stroke Prevention Risk Factors for Stroke

(Stroke. 2002;33:1202.)
© 2002 American Heart Association, Inc.

Original Contributions

Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) Study

Oral Contraceptives and the Risk of Ischemic Stroke

Jeanet M. Kemmeren, PhD; Bea C. Tanis, MD; Maurice A.A.J. van den Bosch, MD; Edward L.E.M. Bollen, MD; Frans M. Helmerhorst, MD; Yolanda van der Graaf, MD; Frits R. Rosendaal, MD Ale Algra, MD

From the Julius Centre for Patient Oriented Research (J.M.K., M.A.A.J.v.d.B., Y.v.d.G., A.A.) and the Department of Neurology (A.A.), University Medical Centre Utrecht, Utrecht, the Netherlands, and the Department of Haematology (B.C.T.), Department of Neurology (E.E.L.M.B.), Department of Obstetrics, Gynecology and Reproductive Medicine (F.M.H.), and the Department of Clinical Epidemiology (F.R.R.), Leiden University Medical Centre, Leiden, the Netherlands.

Reprint requests to Dr A. Algra, Julius Centre for General Practice and Patient Oriented Research, University Medical Centre Utrecht, Room D.01.335, PO Box 85500, 3508 GA Utrecht, Netherlands. E-mail A.Algra{at}neuro.azu.nl

Background and Purpose— Epidemiological studies have shown an increased risk of venous thrombosis in women taking third-generation oral contraceptives, ie, those containing the progestogens desogestrel or gestodene. This study assesses the risk of ischemic stroke with several types of oral contraceptives.

Methods— A multicenter, population-based, case-control study was performed in 9 Dutch centers in women aged 18 to 49 years. Women with a first ischemic stroke were compared with control women without vascular diseases. The control subjects were recruited by random-digit dialing and were stratified by age, area of residence, and year of stroke. All patients and control subjects filled in a questionnaire about the use of oral contraceptives and risk factors for ischemic stroke. Odds ratios were adjusted for the stratification factors.

Results— Two hundred three women with an ischemic stroke and 925 control women were included. The risk of stroke in women using any type of oral contraceptives versus none was 2.3 (95% CI 1.6 to 3.3). Current users of first-generation oral contraceptives had an odds ratio of 1.7 (95% CI 0.7 to 4.4). Low-dose second-generation oral contraceptives increased the risk of stroke 2.4 times (95% CI 1.6 to 3.7), and third-generation oral contraceptives increased the risk of stroke 2.0 times (95% CI 1.2 to 3.5). The risk of stroke in women using third-generation oral contraceptives was not different from that in women using second-generation oral contraceptives (odds ratio 1.0, 95% CI 0.6 to 1.8).

Conclusions— Third-generation oral contraceptives (containing desogestrel or gestodene) confer the same risk of first ischemic stroke as second-generation oral contraceptives (containing levonorgestrel).

Key Words: contraceptives, oral • epidemiology • estrogens • progestins • stroke, ischemic

This article has been cited by other articles:

				D. M. O. Pruissen, A. J. C. Slooter, F. R. Rosendaal, Y. van der Graaf, and A. Algra Coagulation factor XIII gene variation, oral contraceptives, and risk of ischemic stroke Blood, February 1, 2008; 111(3): 1282 - 1286. [Abstract] [Full Text] [PDF]

				The ESHRE Capri Workshop Group Hormones and cardiovascular health in women Hum. Reprod. Update, September 1, 2006; 12(5): 483 - 497. [Abstract] [Full Text] [PDF]

				J.-P. Baillargeon, D. K. McClish, P. A. Essah, and J. E. Nestler Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3863 - 3870. [Abstract] [Full Text] [PDF]

				F. R. Rosendaal Venous Thrombosis: The Role of Genes, Environment, and Behavior Hematology, January 1, 2005; 2005(1): 1 - 12. [Abstract] [Full Text] [PDF]

				D. B. Petitti Combination Estrogen-Progestin Oral Contraceptives N. Engl. J. Med., October 9, 2003; 349(15): 1443 - 1450. [Full Text] [PDF]

				S. Siritho, A. G. Thrift, J. J. McNeil, R. X. You, S. M. Davis, and G. A. Donnan Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill: The Melbourne Risk Factor Study (MERFS) Group Stroke, July 1, 2003; 34(7): 1575 - 1580. [Abstract] [Full Text] [PDF]